Related Experiment Video
Updated: Feb 7, 2026

15:08
Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
10.5K
pSTAT3+ Reactive Astrocytes Promote Brain Metastasis
1Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Trends in Molecular Medicine
|July 22, 2018
Summary
Reactive astrocytes expressing pSTAT3 promote brain metastasis by modifying the tumor microenvironment. These findings highlight pSTAT3-positive reactive astrocytes as a potential therapeutic target for treating brain metastasis.
Area of Science:
- Oncology
- Cancer Biology
- Neuro-oncology
Background:
- The tumor microenvironment (TME) is composed of diverse stromal cells that influence cancer progression and metastasis.
- Understanding the specific cellular components and their roles within the TME is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the role of specific astrocyte populations in the TME.
- To identify novel therapeutic targets for preventing or treating brain metastasis.
Main Methods:
- The study identified and characterized pSTAT3-positive reactive astrocytes within the brain tumor microenvironment.
- Functional assays were performed to assess the impact of these astrocytes on metastasis.
Main Results:
- pSTAT3-positive reactive astrocytes were found to actively promote brain metastasis.
- These astrocytes alter the tumor microenvironment in ways that facilitate metastatic spread to the brain.
Conclusions:
- pSTAT3-positive reactive astrocytes are key drivers of brain metastasis.
- Targeting these specific astrocytes presents a promising therapeutic strategy for combating brain metastasis.
Related Concept Videos
Metastasis
6.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
The Eukaryotic Promoter Region
18.9K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
The Eukaryotic Promoter Region
4.0K
4.0K
Cross-reactivity
33.1K
Overview
33.1K
Reactivity of Enols
4.1K
Enols are a class of compounds where a hydroxyl group is attached to a carbon–carbon double bond, which implies that it is a vinyl alcohol. A carbonyl compound with an α hydrogen undergoes keto–enol tautomerism and remains in equilibrium with its tautomer, the enol form. Usually, the keto tautomer is present in a higher concentration than the enol tautomer due to the higher bond energy of C=O compared to C=C. Moreover, the direction of the keto–enol equilibrium is...
4.1K
Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K

